FDA approves new treatment for patients with hypoplasminogenemia
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type […]
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type […] A new medical technology stops traumatic bleeding without requiring wound compression for Soldiers on the battlefield. Hemorrhaging is a leading […] Researchers at Children's Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PIAX PLUS ASPIRIN 75/100 TABLETS CMI v1 […] Endometrial hyperplasia (EH) is a condition in which the uterine lining is thicker than normal. It may have many causes, […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PARACETAMOL/CODEINE 500/30 Contains the active ingredients, paracetamol […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIZOLE ONE contains the active ingredient fluconazole […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MAXOR HEARTBURN RELIEF omeprazole enteric capsules CONSUMER […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABISART HCTZ contains the active ingredient irbesartan/hydrochlorothiazide […]bleeding
FDA approves new treatment for patients with hypoplasminogenemia
Stopping bleeding saves lives on the battlefield
CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A
Piax Plus Asprin
Prevention and treatment of endometrial hyperplasia
APO-Paracetamol Codeine
Dizole One
Maxor Heartburn Relief
Abisart HCTZ
Copyright © 2024